PRESS RELEASE published on 04/13/2026 at 07:00, 3 months 27 days ago Informations privilégiées / Autres communiqués Innate Pharma a publié le nouveau nombre d'actions et de droits de vote au 9 avril 2026 conformément aux règlements de l'AMF. Découvrez les détails dans le communiqué de presse Droits De Vote Actions AMF Communiqué De Presse Innate Pharma
PRESS RELEASE published on 04/13/2026 at 07:00, 3 months 27 days ago Inside Information / Other news releases Innate Pharma to hold its Annual General Meeting of shareholders on May 21, 2026 at 10:30 a.m. CEST in Marseille. Shareholders must register shares by May 14, 2026, 00:00 Paris time, to attend Annual General Meeting Shareholders Registration Innate Pharma Marseille
BRIEF published on 04/03/2026 at 07:05, 4 months 7 days ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
BRIEF published on 04/03/2026 at 07:05, 4 months 7 days ago Innate Pharma participera à la Kempen Life Sciences Conference Conference Innate Pharma Biotechnologies Immunothérapies Kempen Life Sciences
BRIEF published on 04/03/2026 at 07:05, 4 months 7 days ago Innate Pharma participera à la conférence Kempen Life Sciences Biotechnologie Innate Pharma Réunions Avec Les Investisseurs Conférence De Kempen Immunothérapies Contre Le Cancer
BRIEF published on 04/03/2026 at 07:05, 4 months 7 days ago Innate Pharma will participate in the Kempen Life Sciences Conference Biotechnology Conference Innate Pharma Immunothérapies Kempen Life Sciences
PRESS RELEASE published on 04/03/2026 at 07:00, 4 months 7 days ago Inside Information / Other news releases Innate Pharma to participate in the Kempen Life Sciences Conference on April 15-16, 2026, in Amsterdam, Netherlands. The company is developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients Kempen Life Sciences Conference
PRESS RELEASE published on 04/03/2026 at 07:00, 4 months 7 days ago Informations privilégiées / Autres communiqués Innate Pharma participera à la conférence Kempen Life Sciences à Amsterdam, Pays-Bas, du 15 au 16 avril 2026, pour présenter ses traitements d'immunothérapies contre le cancer Conference Immunothérapie Cancer Innate Pharma Kempen Life Sciences
BRIEF published on 12/11/2025 at 07:05, 7 months 30 days ago Innate Pharma révèle son calendrier financier 2026 Biotechnologie Calendrier Financier Immunothérapie Innate Pharma Résultats 2026
BRIEF published on 12/11/2025 at 07:05, 7 months 30 days ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
Published on 08/11/2026 at 00:40, 5 hours 6 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 5 hours 21 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 6 hours 11 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 6 hours 16 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 6 hours 21 minutes ago Ur-Energy Reports Second Quarter 2026 Results
Published on 08/10/2026 at 22:15, 7 hours 31 minutes ago Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 7 hours 41 minutes ago Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 9 hours 21 minutes ago EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 10 hours 10 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 19:00, 10 hours 46 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026
Published on 08/10/2026 at 18:00, 11 hours 46 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 11 hours 46 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 11:53, 17 hours 52 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
